Back
Astria Therapeutics Stock Price Chart
Sponsored
ATXS
Sponsored
20 Most Hated Stocks on Wall Street
Click here to see the full list and protect yourself before it's too late.
Sell
23
ATXS
Astria Therapeutics
Last Price:
9.77
Seasonality Move:
-21.49%
7 Day Trial
ALL ACCESS PASS
$
7
He cracked the code to crypto
Now he says a new two-year bull market has begun. And he likes one altcoin above all others.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ATXS is experiencing selling pressure, which indicates risk of future bearish movement.
Astria Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.25 | Buy |
20-day SMA: | 10.2 | Sell |
50-day SMA: | 12.65 | Sell |
200-day SMA: | 9.01 | Buy |
8-day EMA: | 9.45 | Sell |
20-day EMA: | 10.32 | Sell |
50-day EMA: | 11.39 | Sell |
200-day EMA: | 10.22 | Sell |
Astria Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.01 | Sell |
Relative Strength Index (14 RSI): | 32.41 | Sell |
Chaikin Money Flow: | -355805 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.34 - 12.1) | Sell |
Bollinger Bands (100): | (7.85 - 14.35) | Sell |
Astria Therapeutics Technical Analysis
Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Astria Therapeutics Stock
Is Astria Therapeutics Stock a Buy?
- Astria Therapeutics share price is 9.35 while ATXS 8-day simple moving average is 9.25, which is a Buy signal.
- The stock price of ATXS is 9.35 while Astria Therapeutics 20-day SMA is 10.20, which makes it a Sell.
- Astria Therapeutics 50-day simple moving average is 12.65 while ATXS share price is 9.35, making it a Sell technically.
- ATXS stock price is 9.35 and Astria Therapeutics 200-day simple moving average is 9.01, creating a Buy signal.
ATXS Technical Analysis vs Fundamental Analysis
Sell
23
Astria Therapeutics (ATXS)
is a Sell
Is Astria Therapeutics a Buy or a Sell?
-
Astria Therapeutics stock is rated a Sell
The current Astria Therapeutics [ATXS] share price is $9.35. The Score for ATXS is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
Astria Therapeutics Stock Info
Market Cap:
513.34M
Price in USD:
9.35
Share Volume:
699.34K
Astria Therapeutics 52-Week Range
52-Week High:
16.90
52-Week Low:
4.26
Sell
23
Astria Therapeutics (ATXS)
is a Sell
Astria Therapeutics Share Price Forecast
-
What is the Astria Therapeutics stock price today?
The Astria Therapeutics stock price is 9.35 USD today. -
Will ATXS stock go up or go down?
Astria Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Astria Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Astria Therapeutics is overvalued.
Is Astria Therapeutics Stock a Buy?
- Astria Therapeutics share price is 9.35 while ATXS 8-day exponential moving average is 9.45, which is a Sell signal.
- The stock price of ATXS is 9.35 while Astria Therapeutics 20-day EMA is 10.32, which makes it a Sell.
- Astria Therapeutics 50-day exponential moving average is 11.39 while ATXS share price is 9.35, making it a Sell technically.
- ATXS stock price is 9.35 and Astria Therapeutics 200-day simple moving average is 10.22, creating a Sell signal.
Technical Analysis of Astria Therapeutics
Should I short Astria Therapeutics stock?
- ATXS Moving Average Covergence Divergence (MACD) indicator is -1.01, suggesting Astria Therapeutics is a Sell
- Astria Therapeutics Relative Strength Index (RSI) is 32.41, which suggest Astria Therapeutics is oversold
- The Bollinger Bands (25) for Astria Therapeutics is (9.34 - 12.1), which suggest Astria Therapeutics is a Sell
- The Bollinger Bands (100) for Astria Therapeutics is (7.85 - 14.35), which suggest Astria Therapeutics is a Sell
* Astria Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.